| Cipla Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500087 |
NSE Symbol : CIPLA |
P/E(TTM) : 32.87 |
|
ISIN Demat : INE059A01026 |
Div & Yield% : 0.93 |
EPS(TTM) : 42.61 |
|
Book Value(₹) : 423.36 |
Market Cap(₹Cr) : 113,154.89 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 20,065.04 | 19,952.49 | 16,574.34 | 14,345.34 | 15,380.82 |
| Other Income | 1,122.65 | 1,279.38 | 1,433.72 | 826.20 | 742.05 |
| Stock Adjustments | 596.45 | 229.87 | -104.57 | -194.32 | 541.93 |
| Total Income | 21,784.14 | 21,461.74 | 17,903.49 | 14,977.22 | 16,664.80 |
| EXPENDITURE : | |||||
| Raw Materials | 6,580.31 | 5,699.59 | 4,977.62 | 4,739.89 | 6,467.54 |
| Power and Fuel Cost | 299.43 | 290.24 | 271.66 | 257.07 | 247.58 |
| Other Manufacturing Expenses | 1,548.61 | 1,374.94 | 997.59 | 710.80 | 919.08 |
| Selling and Administration Expenses | 3,799.01 | 3,493.86 | 2,510.53 | 2,334.97 | 2,107.17 |
| Miscellaneous Expenses | 892.63 | 490.42 | 539.71 | 560.62 | 348.13 |
| Employee Benefit Expenses | 3,350.48 | 3,054.87 | 2,688.51 | 2,380.68 | 2,122.02 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 5,313.67 | 7,057.82 | 5,917.87 | 3,993.19 | 4,453.28 |
| Interest | 19.30 | 15.11 | 20.25 | 22.27 | 26.93 |
| Gross Profit | 5,294.37 | 7,042.71 | 5,897.62 | 3,970.92 | 4,426.35 |
| Depreciation | 658.43 | 573.89 | 587.59 | 595.91 | 546.62 |
| Profit Before Tax | 4,635.94 | 6,468.82 | 5,310.03 | 3,375.01 | 3,879.73 |
| Current Tax | 1,101.90 | 1,360.32 | 1,226.69 | 901.63 | 949.49 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 18.86 | -49.15 | 6.09 | -40.09 | -27.69 |
| Reported Net Profit | 3,515.18 | 5,157.65 | 4,077.25 | 2,513.47 | 2,957.93 |
| Extraordinary Items | 72.74 | 344.27 | 39.14 | -41.59 | 48.88 |
| Adjusted Net Profit | 3,442.44 | 4,813.38 | 4,038.11 | 2,555.06 | 2,909.05 |
| Adjustment below Net Profit | -13.52 | -12.96 | -74.47 | -10.52 | 18.48 |
| Profit/Loss Balance carried down | 27,045.69 | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,292.40 | 1,049.83 | 686.17 | 403.50 | 403.35 |
| P & L Balance carried down | 29,254.95 | 27,045.69 | 22,950.83 | 19,634.22 | 17,534.77 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 650.00 | 800.00 | 650.00 | 425.00 | 250.00 |
| Dividend Per Share(Rs) | 13.00 | 16.00 | 13.00 | 8.50 | 5.00 |
| Earnings Per Share-Unit Curr | 43.52 | 63.86 | 50.50 | 31.14 | 36.66 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 423.39 | 397.46 | 346.49 | 305.25 | 279.05 |
| Book Value(Adj)-Unit Curr | 423.39 | 397.46 | 346.49 | 305.25 | 279.05 |
